These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37378614)

  • 1. Tailoring the Inherent Properties of Biobased Nanoparticles for Nanomedicine.
    Zahid AA; Chakraborty A; Luo W; Coyle A; Paul A
    ACS Biomater Sci Eng; 2023 Jul; 9(7):3972-3986. PubMed ID: 37378614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomimicking Extracellular Vesicles with Fully Artificial Ones: A Rational Design of EV-BIOMIMETICS toward Effective Theranostic Tools in Nanomedicine.
    Rosso G; Cauda V
    ACS Biomater Sci Eng; 2023 Nov; 9(11):5924-5932. PubMed ID: 36535896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge Gaps in Generating Cell-Based Drug Delivery Systems and a Possible Meeting with Artificial Intelligence.
    Mozafari N; Mozafari N; Dehshahri A; Azadi A
    Mol Pharm; 2023 Aug; 20(8):3757-3778. PubMed ID: 37428824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shape-specific polymeric nanomedicine: emerging opportunities and challenges.
    Tao L; Hu W; Liu Y; Huang G; Sumer BD; Gao J
    Exp Biol Med (Maywood); 2011 Jan; 236(1):20-9. PubMed ID: 21239732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying artificial intelligence and computational modeling to nanomedicine.
    Hamilton S; Kingston BR
    Curr Opin Biotechnol; 2024 Feb; 85():103043. PubMed ID: 38091874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted nanomedicine: Lessons learned and future directions.
    Veiga N; Diesendruck Y; Peer D
    J Control Release; 2023 Mar; 355():446-457. PubMed ID: 36773958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.
    Pridgen EM; Langer R; Farokhzad OC
    Nanomedicine (Lond); 2007 Oct; 2(5):669-80. PubMed ID: 17976029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red blood cells membrane-derived nanoparticles: Applications and key challenges in their clinical translation.
    Malhotra S; Dumoga S; Singh N
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1776. PubMed ID: 35106966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic cells in biomedical applications.
    Sato W; Zajkowski T; Moser F; Adamala KP
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Mar; 14(2):e1761. PubMed ID: 34725945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocytosis at the nanoscale.
    Canton I; Battaglia G
    Chem Soc Rev; 2012 Apr; 41(7):2718-39. PubMed ID: 22389111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in mesenchymal stem cell membrane-coated nanoparticles for enhanced drug delivery.
    Wang M; Xin Y; Cao H; Li W; Hua Y; Webster TJ; Zhang C; Tang W; Liu Z
    Biomater Sci; 2021 Feb; 9(4):1088-1103. PubMed ID: 33332490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current in vitro approaches to assess nanoparticle interactions with lung cells.
    Fytianos K; Drasler B; Blank F; von Garnier C; Seydoux E; Rodriguez-Lorenzo L; Petri-Fink A; Rothen-Rutishauser B
    Nanomedicine (Lond); 2016 Sep; 11(18):2457-69. PubMed ID: 27529369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical quality attributes in the development of therapeutic nanomedicines toward clinical translation.
    Taha MS; Padmakumar S; Singh A; Amiji MM
    Drug Deliv Transl Res; 2020 Jun; 10(3):766-790. PubMed ID: 32170656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy.
    Doane TL; Burda C
    Chem Soc Rev; 2012 Apr; 41(7):2885-911. PubMed ID: 22286540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theranostic nanoparticles engineered for clinic and pharmaceutics.
    Ma X; Zhao Y; Liang XJ
    Acc Chem Res; 2011 Oct; 44(10):1114-22. PubMed ID: 21732606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promising effects of nanomedicine in cancer drug delivery.
    Wakaskar RR
    J Drug Target; 2018 Apr; 26(4):319-324. PubMed ID: 28875739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomimetic cell-derived nanocarriers in cancer research.
    Soprano E; Polo E; Pelaz B; Del Pino P
    J Nanobiotechnology; 2022 Dec; 20(1):538. PubMed ID: 36544135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
    Yang Y; Zhang M; Song H; Yu C
    Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small.
    Tyagi P; Subramony JA
    J Control Release; 2018 Feb; 272():159-168. PubMed ID: 29355619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecularly targeted nanomedicine enabled by inorganic nanoparticles for atherosclerosis diagnosis and treatment.
    Zhang X; Centurion F; Misra A; Patel S; Gu Z
    Adv Drug Deliv Rev; 2023 Mar; 194():114709. PubMed ID: 36690300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.